ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more
Industry PharmaceuticalsGeneric
A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.
| Ticker / NAME | Correlation To ADCT | 1D Price Change % | ||
|---|---|---|---|---|
| ADCT | 100% | -0.77% | ||
| QTTB - ADCT | 45% Loosely correlated | -10.96% | ||
| CLRB - ADCT | 43% Loosely correlated | +1.81% | ||
| SEPN - ADCT | 37% Loosely correlated | -5.05% | ||
| AXON - ADCT | 36% Loosely correlated | -2.78% | ||
| RCUS - ADCT | 35% Loosely correlated | -3.47% | ||
More | ||||
| Ticker / NAME | Correlation To ADCT | 1D Price Change % |
|---|---|---|
| ADCT | 100% | -0.77% |
| Pharmaceuticals: Generic industry (85 stocks) | -0% Poorly correlated | -1.27% |
| Pharmaceuticals industry (160 stocks) | -6% Poorly correlated | -0.83% |
The RSI Indicator for ADCT moved out of oversold territory on July 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on June 30, 2026. You may want to consider a long position or call options on ADCT as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ADCT just turned positive on June 23, 2026. Looking at past instances where ADCT's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ADCT advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where ADCT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ADCT broke above its upper Bollinger Band on July 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ADCT entered a downward trend on June 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (46.335). P/E Ratio (0.000) is within average values for comparable stocks, (99.004). ADCT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.679). ADCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.036). P/S Ratio (2.261) is also within normal values, averaging (114.736).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ADCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.